Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Hindu
The Hindu
National
Special Correspondent

Now, a bio-drug derived from turmeric to treat cancer

CSIR-Centre for Cellular & Molecular Biology (CCMB) scientists in collaboration with CSIR-National Chemical Laboratory (NCL) announced on Thursday that they have made progress towards developing a non-toxic bio-drug derived from turmeric through a ‘gene silencing approach’ to treat cancer.

Promising tool

‘RNA interference (RNAi)’ is a gene silencing approach and a promising tool for targeted and focused therapy for chronic diseases like cancer. The lack of safe and effective delivery methods for RNAi molecules is one of the key challenges against using RNAi-based therapy in biological systems.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.